These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 37296584)

  • 21. [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
    Gomazkov OA
    Eksp Klin Farmakol; 2015; 78(11):35-44. PubMed ID: 27017704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Anticancer Agents Med Chem; 2017; 17(2):190-205. PubMed ID: 27109020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes.
    Peixoto P; Grandvallet C; Feugeas JP; Guittaut M; Hervouet E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating epigenetic modifications for cancer therapy (Review).
    Castro-Muñoz LJ; Ulloa EV; Sahlgren C; Lizano M; De La Cruz-Hernández E; Contreras-Paredes A
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
    Ganai SA; Banday S; Farooq Z; Altaf M
    Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises.
    Panduga S; Vasishta S; Subramani R; Vincent S; Mutalik S; Joshi MB
    Eur J Pharmacol; 2024 Jul; ():176827. PubMed ID: 39038635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidrugs in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia: Contextualizing a Role for Histone Kinase Inhibition in Neurodegenerative Disease.
    Cobos SN; Torrente MP
    ACS Pharmacol Transl Sci; 2022 Feb; 5(2):134-137. PubMed ID: 35187420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classical HDACs in the regulation of neuroinflammation.
    Dai Y; Wei T; Shen Z; Bei Y; Lin H; Dai H
    Neurochem Int; 2021 Nov; 150():105182. PubMed ID: 34509559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Hydrogen Sulfide in Regulation of Cell Death following Neurotrauma and Related Neurodegenerative and Psychiatric Diseases.
    Rodkin S; Nwosu C; Sannikov A; Raevskaya M; Tushev A; Vasilieva I; Gasanov M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs.
    Rath S; Perikala V; Jena AB; Dandapat J
    Biomed Pharmacother; 2021 Nov; 143():112095. PubMed ID: 34479017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders.
    Sebastiani G; Almeida-Toledano L; Serra-Delgado M; Navarro-Tapia E; Sailer S; Valverde O; Garcia-Algar O; Andreu-Fernández V
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular Nerve Growth Factor (NGF) and NGF Eye Drop Application as Paradigms to Investigate NGF Neuroprotective and Reparative Actions.
    Tirassa P; Rosso P; Iannitelli A
    Methods Mol Biol; 2018; 1727():19-38. PubMed ID: 29222770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer.
    Guerra J; Devesa J
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
    Yousaf M; Chang D; Liu Y; Liu T; Zhou X
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multitarget Drugs: an Epigenetic Epiphany.
    Ganesan A
    ChemMedChem; 2016 Jun; 11(12):1227-41. PubMed ID: 26891251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
    Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
    Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.